It is a great question regarding competition. IMO the key benefits to this technology is low cost and portability (by comparison with CT or MRI). EMV seems to have a more compact unit by comparison with competitors which is less invasive – only need to raise the patients head rather than their whole body. More importantly, it appears our unit could easily fit in an ambulance and be moved around the hospital by a single person. The other big competitive advantage is our partners and management. And these were probably attracted to EMV based on the first point. Cost, portability and quality of tech out of UQ. GE Healthcare is the most telling of our partners but we also have Keysight, Australian Government and Australian Stoke Alliance. And then there is our management team… These people do not belong working for a 30m AUD market cap company lol… One example is the co-inventor of the underlying tech is globally renowned with patents in 70% of installed MRI’s…. Great potential here and looking forward to the trials. All IMO.
EMvision Research Notes, page-47
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.90 |
Change
-0.050(2.56%) |
Mkt cap ! $162.3M | |||
| Open | High | Low | Value | Volume |
| $1.90 | $1.96 | $1.84 | $169.8K | 90.56K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 171 | $1.84 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.90 | 2701 | 1 |
View Market Depth
| Last trade - 16.10pm 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.86 |
Change
-0.050 ( 4.62 %) |
||||
| Open | High | Low | Volume | ||
| $1.96 | $1.96 | $1.85 | 521600 | ||
| Last updated 15.59pm 17/05/2024 ? | |||||
| EMV (ASX) Chart |